| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 06/16/2004 | EP0977725B1 New fatty acid derivatives |
| 06/16/2004 | CN1505603A Substituted benzoic ac id derivatives exhibiting nf-ª—b inhibiting activity |
| 06/16/2004 | CN1504752A Vaughan Tristan J. |
| 06/16/2004 | CN1504200A Red-legged disease, curlworm disease ecotype, immunity and prevention and cure technique of eelworm |
| 06/16/2004 | CN1153582C Veterinary liniment containing azedarachin and its preparation |
| 06/16/2004 | CN1153574C Use of bacterial cell wall extracts for treating, preventing or removing protozoan or parasite diseases |
| 06/16/2004 | CN1153510C Vaccination against coccidiosis in ovum |
| 06/16/2004 | CN1153509C Vaccination against coccidiosis in ovum |
| 06/10/2004 | WO2004047803A1 An injection of animal remedy including closantel or closantel sodium |
| 06/10/2004 | WO2004024132A3 Use of no-signal cascade modulators and pharmaceutical composition |
| 06/10/2004 | WO2004022569A9 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 06/10/2004 | WO2004003235A3 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 06/10/2004 | WO2003072027A3 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 06/10/2004 | US20040110952 e.g., N-[1-(3-phenyl-3-[cyclopenytlacetylamino]propyl)-4-piperidinyl]-N-ethyl-4-methanesulfonylphenylacetamide |
| 06/10/2004 | US20040110810 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 06/10/2004 | US20040110794 Novel piperidine derivatives as modulators of chemokine receptors |
| 06/10/2004 | US20040110772 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 06/10/2004 | US20040110759 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 06/10/2004 | US20040110728 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 06/10/2004 | US20040110695 Phospholipid vesicle having exogenous antigen orpolynucleic acid coding for antigen; adapted to be phagocytosed by antigen presenting cells |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040109883 Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
| 06/10/2004 | CA2721200A1 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 06/09/2004 | EP1425303A2 Use of proteins for the production of a medicament for stimulating the innate non specific immune system |
| 06/09/2004 | EP1425035A1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 06/09/2004 | EP1424994A1 Preparation of sustained release pharmaceutical composition |
| 06/09/2004 | EP1043978B1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 06/09/2004 | CN1503788A Novel azoles having an insecticidal action |
| 06/09/2004 | CN1152676C Combination preparation for treating malaria |
| 06/08/2004 | US6747053 Heteroaryl nitriles |
| 06/08/2004 | US6747040 Imidazonaphthyridines |
| 06/08/2004 | US6747014 For therapy of inflammatory bowel disorder |
| 06/03/2004 | WO2004013306A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 06/03/2004 | WO2003088995A3 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
| 06/03/2004 | WO2003024481A3 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 06/03/2004 | US20040106805 optionally oxa-, thia- or hydrocarbylaza-substituted pentalenones, e.g., 3aR, 6aR) 4-tert-Butyl-N-[2-(4-hydroxyphenyl)-1S-(3-oxo-hexahydrocyclopenta[b]furan-3a-ylcChagas' diseasearbamoyl)-ethyl]benzamide; treating Chagas' disease |
| 06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106686 Antihelminthic anthraquinones and method of use thereof |
| 06/03/2004 | US20040106666 Hydroxamic acid or n-formyl hydroxylamine derivatives as inhibitors of bakterial polypeptide deformylase for treating microbial infections |
| 06/03/2004 | US20040106658 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides(III) |
| 06/03/2004 | US20040106641 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 06/03/2004 | US20040106640 Aryl ether substituted imidazoquinolines |
| 06/03/2004 | US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation |
| 06/03/2004 | US20040106562 Drugs containing reduced of vitamin b2 |
| 06/03/2004 | US20040105841 Interferons, uses and compositions related thereto |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423421A2 Isolation and purification of p. falciparum merozoite protein-1 42 vaccine |
| 06/02/2004 | EP1423121A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 06/02/2004 | EP1423095A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/02/2004 | EP1423006A1 Agonists and antagonists of 5h 3?-like receptors of invertebrate s as pesticides |
| 06/02/2004 | EP1171113B1 Compounds useful as phosphotyrosine mimics |
| 06/02/2004 | EP1087952B1 Benzazole compounds and their use |
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1501918A Halogen-substituted quinoline derivatives and ectoparasite control agent |
| 06/02/2004 | CN1501827A Ligands of the alpha-v-beta 6 integrin |
| 06/02/2004 | CN1501773A Liquid formulations for dernal application in treatment of parasitic insects in animals |
| 06/02/2004 | CN1500492A Veterinary antiparasite suspension injection |
| 06/02/2004 | CN1151799C Bacterial membrane fractions with adjuvant effect |
| 06/01/2004 | US6743814 Reacting 4-bromo-1,1,2-trifluoro-1-butene with 2-mercapto-oxazole |
| 05/27/2004 | WO2004044214A1 Novel substance fki-1033 and process for producing the same |
| 05/27/2004 | WO2004043488A1 Malaria vaccine |
| 05/27/2004 | WO2004043446A2 Combination product for controlling insect pests |
| 05/27/2004 | WO2004043428A2 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/27/2004 | WO2004009762A3 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 05/27/2004 | WO2003004604A3 Phage displayed pdz domain ligands |
| 05/27/2004 | US20040102471 Viricides; anticancer agents |
| 05/27/2004 | US20040102431 Protease inhibitors |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102366 A homogeneous cyclosporin solution comprising a carrier dialkyl ester of aliphatic or aromatic dioic acid, hydrophilic lipophilic balance, forming emulsions in stomach with gastrointestinal fluids |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101865 Comprises nucleotide sequences coding polypeptides associated with biosynthesis and metabolism of acetyl-CoA for preparing food, feed, cosmetics and pharmaceutical agents |
| 05/27/2004 | CA2505724A1 Malaria vaccine |
| 05/27/2004 | CA2504309A1 Novel substance fki-1033 and process for producing the same |
| 05/27/2004 | CA2502427A1 Combination product for controlling insect pests |
| 05/27/2004 | CA2497268A1 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/26/2004 | EP1422234A2 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone |
| 05/26/2004 | EP1420829A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 05/26/2004 | EP1420818A1 Antigenic compositions |
| 05/26/2004 | EP1420804A1 Methods and compositions for control of coccidiosis |
| 05/26/2004 | EP1420783A1 Stable emulsion composition |
| 05/26/2004 | EP1420645A1 Multivesicular emulsion topical delivery systems |
| 05/26/2004 | EP1420644A1 Substituted propargylamines |
| 05/26/2004 | EP1206258B1 Compositions containing esters for treating parasitic infestations of organisms |
| 05/26/2004 | CN1499963A Parasiticidal compsns. and methods of use |
| 05/21/2004 | WO2004041167A2 Antiprotozoal ring-substituted phospholipids |
| 05/21/2004 | WO2004005476A3 Nucleic acid compositions for stimulating immune responses |
| 05/21/2004 | WO2003084935A3 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases |
| 05/21/2004 | WO2003072725A3 Recombinant negative strand virus rna expression systems and vaccines |
| 05/21/2004 | WO2003053399A3 Methods for wet granulating azithromycin |
| 05/21/2004 | WO2002102307B1 Nucleoside vaccine adjuvants |
| 05/21/2004 | WO2000032745A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/21/2004 | CA2503058A1 Antiprotozoal ring-substituted phospholipids |
| 05/20/2004 | US20040097494 For use as nitric oxide synthase inhibitors |
| 05/20/2004 | US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies |
| 05/20/2004 | US20040096466 Plasmodium falciparum antigens inducing protective antibodies |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |